27.22
Overview
News
Price History
Option Chain
Why PHG Down?
Discussions
Forecast
Stock Split
Dividend History
Koninklijke Philips Nv Adr stock is traded at $27.22, with a volume of 795.52K.
It is up +1.83% in the last 24 hours and down -4.39% over the past month.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
See More
Previous Close:
$26.74
Open:
$26.905
24h Volume:
795.52K
Relative Volume:
0.74
Market Cap:
$25.92B
Revenue:
$20.45B
Net Income/Loss:
$1.12B
P/E Ratio:
23.35
EPS:
1.1658
Net Cash Flow:
$1.75B
1W Performance:
+6.78%
1M Performance:
-4.39%
6M Performance:
-0.11%
1Y Performance:
+16.22%
Koninklijke Philips Nv Adr Stock (PHG) Company Profile
Name
Koninklijke Philips Nv Adr
Sector
Industry
Phone
-
Address
-
Compare PHG vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PHG
Koninklijke Philips Nv Adr
|
27.23 | 25.46B | 20.45B | 1.12B | 1.75B | 1.1658 |
|
ABT
Abbott Laboratories
|
87.75 | 153.94B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
316.09 | 123.25B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
77.75 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.01 | 84.23B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
83.37 | 47.77B | 6.30B | 1.07B | 1.09B | 1.8406 |
Koninklijke Philips Nv Adr Stock (PHG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-25 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-25-25 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Feb-20-25 | Upgrade | UBS | Neutral → Buy |
| Oct-29-24 | Upgrade | Jefferies | Underperform → Hold |
| May-13-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| May-07-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Apr-30-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Apr-30-24 | Upgrade | UBS | Sell → Neutral |
| Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| Jul-12-23 | Initiated | Goldman | Buy |
| Jan-17-23 | Downgrade | UBS | Neutral → Sell |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-14-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Sep-12-22 | Upgrade | Societe Generale | Hold → Buy |
| Sep-06-22 | Upgrade | UBS | Sell → Neutral |
| Jul-25-22 | Downgrade | Societe Generale | Buy → Hold |
| Jun-16-22 | Downgrade | UBS | Neutral → Sell |
| Jan-20-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-14-22 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-08-21 | Initiated | Jefferies | Buy |
| Jul-08-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Jun-21-21 | Downgrade | HSBC Securities | Buy → Hold |
| Mar-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-28-20 | Initiated | Societe Generale | Buy |
| Jul-30-19 | Initiated | Citigroup | Buy |
| Feb-12-18 | Upgrade | Berenberg | Hold → Buy |
| Nov-09-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Oct-16-17 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jun-21-17 | Downgrade | Natixis Bleichroeder | Buy → Neutral |
| Apr-25-17 | Downgrade | Societe Generale | Buy → Hold |
| Dec-12-16 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-16 | Initiated | Citigroup | Buy |
| May-11-16 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-01-16 | Upgrade | HSBC Securities | Reduce → Hold |
| Feb-16-16 | Downgrade | Jefferies | Hold → Underperform |
| Nov-27-15 | Initiated | ING Group | Hold |
| Sep-08-15 | Initiated | Credit Suisse | Outperform |
| Aug-27-15 | Upgrade | Nomura | Neutral → Buy |
| Jul-28-15 | Upgrade | Societe Generale | Hold → Buy |
| Jan-25-11 | Downgrade | HSBC Securities | Overweight → Neutral |
| Dec-07-09 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-16-09 | Upgrade | HSBC Securities | Neutral → Overweight |
| May-08-09 | Downgrade | UBS | Buy → Neutral |
View All
Koninklijke Philips Nv Adr Stock (PHG) Latest News
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Philips introduces SmartIQ to address the trade-off between image quality and radiation dose in coronary procedures - Sahm
Nebulizers - GlobeNewswire Inc.
Koninklijke Philips N.V. stock (NL0000009538): new SmartIQ imaging launch keeps focus on health-tech - AD HOC NEWS
Philips highlights advances in imaging and physiology to support complex PCI at EuroPCR 2026 - GlobeNewswire Inc.
Philips to deliver vital technology for hospital-at-home care for up to 15,000 patients annually in Region Stockholm - Finviz
PHGKoninklijke Philips NV ADR Stock Price and Quote - Finviz
Koninklijke Philips N.V. ADR Unsponsored Brazilian Depository Receipt Repr 1 ADR - TradingView
QuickLogic Posts Downbeat Q1 Results, Joins Resideo Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Koninklijke Philips N.V. stock (NL0000009538): ex-dividend date set for May 12 - AD HOC NEWS
Koninklijke Philips N.V. Stock (NL0000009538): Analyst Rating Change and Price Move on May 7, 2026 - AD HOC NEWS
Philips shareholders approve all proposals at the AGM 2026 - Finviz
Earnings call transcript: Philips Q1 2026 sees solid revenue but EPS miss - Investing.com
Earnings call transcript: Koninklijke Philips misses Q1 2026 EPS forecast By Investing.com - Investing.com Canada
Earnings call transcript: Koninklijke Philips misses Q1 2026 EPS forecast - Investing.com
Philips Reports Strong Order Intake Despite Uncertain Macro Environment - Sahm
Sleep Apnea Devices (Therapeutic, Diagnostic) Market Report 2026-2034 Featuring Key Players - GlobeNewswire Inc.
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Sony Group Corp. ADR falls Thursday, underperforms market - MarketWatch
Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction - Sahm
Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning - Finviz
Sony Group Corp. ADR falls Monday, underperforms market - MarketWatch
Koninklijke Philips (ADR) stock (NL0000009538): Why Google Discover changes matter more now - AD HOC NEWS
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Sahm
Sony Group Corp. ADR rises Friday, still underperforms market - MarketWatch
Philips receives FDA 510(k) clearance for Verida, the world's first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications - Finviz
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
Koninklijke Philips (ADR) stock (NL0000009538): Why its focus on diagnostics and AI tools matters mo - AD HOC NEWS
Koninklijke Philips (ADR) stock (NL0000009538): Why its focus on healthcare innovation matters more - AD HOC NEWS
Koninklijke Philips N.V. (PHG) Stock Price, News, Quote & History - Yahoo! Finance Canada
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member - Sahm
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair - Finviz
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care - Finviz
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant - Sahm
Philips convenes the Annual General Meeting of Shareholders 2026 - Finviz
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment - Finviz
Sony Group Corp. ADR falls Wednesday, underperforms market - MarketWatch
Koninklijke Philips N.V. Stock (ISIN: NL0000009538) Holds Steady Amid Neutral Analyst Views and AI-D - AD HOC NEWS
Koninklijke Philips (ADR) Stock Gains Traction as Earnings Beat Expectations Amid Health Tech Recove - AD HOC NEWS
PHIA Stock Price and Chart — EURONEXT:PHIA - TradingView
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite - Finviz
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 - Finviz
NVIDIA Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Philips Sonicare unveils two new electric toothbrush ranges alongside refreshed brand direction - Finviz
Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments - Finviz
Koninklijke Philips Nv Adr Stock (PHG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):